Form 4: Zynex Inc. Director Joshua R. Disbrow Reports Acquisition of Restricted Stock Award

Director Joshua R. Disbrow reports acquisition of 10,000 shares of restricted stock in Zynex Inc. with vesting over three years.

Summary

• On May 16, 2024, Joshua R. Disbrow, a director of Zynex Inc., reported acquiring 10,000 shares of common stock as a restricted stock award.
• The award was issued under the company's 2017 Stock Incentive Plan.
• The shares vest equally on a quarterly basis over three years, starting one quarter from the grant date.
• Following the transaction, Disbrow beneficially owns 22,587 shares of restricted stock awards that have not vested.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard executive compensation practice. The vesting schedule is a positive sign of long-term commitment.

Positives

• The grant of restricted stock aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The vesting of the restricted stock award over the next three years suggests an expectation of continued service and contribution from the director.

Industry Context

Stock awards are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Stakeholder Impact

• The stock award aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term performance.
• Employees may view the stock award as a positive sign of the company's commitment to its leadership.

Key Dates